| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' M Niino, K Iwabuchi, S Kikuchi, M Ato, T Morohashi, A Ogata, K Tashiro, K Ono\\xc3\\xa. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. Journal of neuroimmunology. vol 116. issue 1. 2001-05-10. PMID:11311328.' |
in the present study, we examined whether troglitazone, a selective ppar-gamma agonists, ameliorated experimental autoimmune encephalomyelitis (eae) induced by administration of myelin oligodendrocyte glycoprotein (mog) peptide 35-55 in c57bl/6 mice. |
2001-05-10 |
2023-08-12 |
mouse |
| N Hellings, M Barée, C Verhoeven, M B D'hooghe, R Medaer, C C Bernard, J Raus, P Stinisse. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. Journal of neuroscience research. vol 63. issue 3. 2001-04-26. PMID:11170179. |
myelin proteins, including myelin basic protein (mbp), proteolipid protein (plp) and myelin oligodendrocyte glycoprotein (mog) are candidate autoantigens in ms. |
2001-04-26 |
2023-08-12 |
human |
| T Berger, M Reind. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis. Journal of neural transmission. Supplementum. issue 60. 2001-04-12. PMID:11205153. |
immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (mog) in multiple sclerosis. |
2001-04-12 |
2023-08-12 |
Not clear |
| T Berger, M Reind. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis. Journal of neural transmission. Supplementum. issue 60. 2001-04-12. PMID:11205153. |
this present article will discuss recently published and some preliminary data on the immunopathogenic role of antibodies against myelin oligodendrocyte glycoprotein (mog) and other myelin/nonmyelin targets in multiple sclerosis, as well as possible clinical implications for prognosis and therapy in the future. |
2001-04-12 |
2023-08-12 |
Not clear |
| C G Haase, J Guggenmos, U Brehm, M Andersson, T Olsson, M Reindl, J M Schneidewind, U K Zettl, F Heidenreich, T Berger, H Wekerle, R Hohlfeld, C Liningto. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. Journal of neuroimmunology. vol 114. issue 1-2. 2001-04-12. PMID:11240035. |
antibodies directed against the extracellular immunoglobulin (ig)-like domain of the myelin oligodendrocyte glycoprotein (mog(igd)) mediate demyelination in experimental autoimmune encephalomyelitis (eae) and are implicated in the immunopathogenesis of multiple sclerosis (ms). |
2001-04-12 |
2023-08-12 |
human |
| H Hackstein, A Bitsch, A Bohnert, H Hofmann, F Weber, A Ohly, C Linington, M Mäurer, S Poser, P Rieckmann, G Bei. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis. Journal of neuroimmunology. vol 113. issue 2. 2001-03-22. PMID:11164908. |
analysis of the first 100 ms patients for six il4r variants showed an increased frequency of the r551 variant in ms patients versus healthy controls and carriage of the same il4r variant was weakly associated with myelin oligodendrocyte glycoprotein (mog) autoantibody production. |
2001-03-22 |
2023-08-12 |
Not clear |
| J R Kanwar, R K Kanwar, D Wang, G W Krissanse. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunology and cell biology. vol 78. issue 6. 2001-03-08. PMID:11114975. |
in the present paper, it is shown that an antibody directed against madcam-1, the preferential ligand for alpha4beta7, effectively prevented the development of a progressive, non-remitting, form of eae, actively induced by injection of myelin oligodendrocyte glycoprotein peptide (mog(35-55)) autoantigen. |
2001-03-08 |
2023-08-12 |
Not clear |
| B N Ditte. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Archivum immunologiae et therapiae experimentalis. vol 48. issue 5. 2001-03-08. PMID:11140465. |
active immunization of mice with several different protein components of myelin, including myelin basic protein (mbp), proteolipid protein (plp) and myelin oligodendrocyte glycoprotein (mog), are capable of eliciting an immune response resulting in the quintessential symptoms of eae: ascending paralysis involving the tail and then the limbs. |
2001-03-08 |
2023-08-12 |
mouse |
| B Crouau-Roy, I Clisso. Evolution of an Alu DNA element of type Sx in the lineage of primates and the origin of an associated tetranucleotide microsatellite. Genome. vol 43. issue 4. 2001-03-01. PMID:10984176. |
a 394-bp dna fragment, which in human is on chromosome 6 near the mog (myelin oligodendrocyte glycoprotein) gene and encompasses an alu element and an associated tetranucleotide microsatellite, was sequenced from a large range of primate species to follow its evolutionary divergence and to understand the origin of the microsatellite. |
2001-03-01 |
2023-08-12 |
human |
| A Stefferl, U Brehm, C Liningto. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. Journal of neural transmission. Supplementum. issue 58. 2001-02-22. PMID:11128602. |
the myelin oligodendrocyte glycoprotein (mog): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. |
2001-02-22 |
2023-08-12 |
Not clear |
| A Stefferl, U Brehm, C Liningto. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. Journal of neural transmission. Supplementum. issue 58. 2001-02-22. PMID:11128602. |
the myelin oligodendrocyte glycoprotein (mog) is a major target for autoantibody mediated demyelination in experimental autoimmune encephalomyelitis (eae). |
2001-02-22 |
2023-08-12 |
Not clear |
| J Fisher, H Levkovitch-Verbin, H Schori, E Yoles, O Butovsky, J F Kaye, A Ben-Nun, M Schwart. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 21. issue 1. 2001-02-08. PMID:11150329. |
before severe crush injury of the optic nerve, sjl/j and c3h.sw mice were actively immunized with encephalitogenic or nonencephalitogenic peptides of proteolipid protein (plp) or myelin oligodendrocyte glycoprotein (mog), respectively. |
2001-02-08 |
2023-08-12 |
mouse |
| C Bourquin, A Iglesias, T Berger, H Wekerle, C Liningto. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. European journal of immunology. vol 30. issue 12. 2001-01-26. PMID:11169409. |
we assessed the potential of vaccination with a dna construct encoding the myelin oligodendrocyte glycoprotein (mog), an important candidate autoantigen in multiple sclerosis, to induce tolerance and protect against experimental autoimmune encephalomyelitis (eae). |
2001-01-26 |
2023-08-12 |
mouse |
| L S Harbige, L Layward, M M Morris-Downes, D C Dumonde, S Amo. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clinical and experimental immunology. vol 122. issue 3. 2001-01-11. PMID:11122253. |
eae was induced by an encephalitogenic peptide (92-106) of myelin oligodendrocyte glycoprotein (mog), and mice were fed the plant lipid daily from 7 days after eae induction to assess the effects on acute disease and from day 25 to assess the effects on disease relapse. |
2001-01-11 |
2023-08-12 |
mouse |
| M Gomez-Lira, M G Marzari, G Uziel, P Pignatti, N Rizzuto, A Salviat. Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy. Journal of neuroimmunology. vol 111. issue 1-2. 2000-12-22. PMID:11063846. |
myelin oligodendrocyte glycoprotein (mog) polymorphisms and adrenoleukodystrophy. |
2000-12-22 |
2023-08-12 |
Not clear |
| M Gomez-Lira, M G Marzari, G Uziel, P Pignatti, N Rizzuto, A Salviat. Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy. Journal of neuroimmunology. vol 111. issue 1-2. 2000-12-22. PMID:11063846. |
we describe four novel sequence variants in the myelin oligodendrocyte glycoprotein (mog) gene. |
2000-12-22 |
2023-08-12 |
Not clear |
| M Yoshino, H Xiao, E P Jones, K Fischer Lindah. BAC/YAC contigs from the H2-M region of mouse Chr 17 define gene order as Znf173-Tctex5-mog-D17Tu42-M3-M2. Immunogenetics. vol 47. issue 5. 2000-12-14. PMID:9510555. |
a bacterial artificial chromosome (bac) contig from the 129 (h2(bc)) mouse, spanning approximately 600 kilobases, was also built from znf173 (afp, a gene for acid finger protein), through tctex5 (t-complex testis expressed-5) and mog (myelin oligodendrocyte glycoprotein), to h2-m2. |
2000-12-14 |
2023-08-12 |
mouse |
| T Litzenburger, H Blüthmann, P Morales, D Pham-Dinh, A Dautigny, H Wekerle, A Iglesia. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein. Journal of immunology (Baltimore, Md. : 1950). vol 165. issue 9. 2000-11-30. PMID:11046072. |
we explored mechanisms involved in b cell self-tolerance against brain autoantigens in a double-transgenic mouse model carrying the ig h-chain (introduced by gene replacement) and/or the l-chain kappa (conventional transgenic) of the mab 8.18c5, specific for the myelin oligodendrocyte glycoprotein (mog). |
2000-11-30 |
2023-08-12 |
mouse |
| N Kerlero de Rosbo, H P Brok, J Bauer, J F Kaye, B A 't Hart, A Ben-Nu. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes. Journal of neuroimmunology. vol 110. issue 1-2. 2000-11-13. PMID:11024537. |
eight rhesus monkeys with different mhc backgrounds were immunized with myelin oligodendrocyte glycoprotein (mog). |
2000-11-13 |
2023-08-12 |
monkey |
| A B Bakker, R M Hoek, A Cerwenka, B Blom, L Lucian, T McNeil, R Murray, L H Phillips, J D Sedgwick, L L Lanie. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. vol 13. issue 3. 2000-10-18. PMID:11021532. |
dap12-/- mice were resistant to eae induced by immunization with myelin oligodendrocyte glycoprotein (mog) peptide. |
2000-10-18 |
2023-08-12 |
mouse |